Rapid Novor: Selected Partner

Rapid Novor’s innovative next-generation protein sequencing technology enables researchers to confidently sequence and recombinantly express monoclonal antibodies from small protein samples of any species.

Key facts

• Specialization: Antibody discovery and sequencing services
• Technology: Next-generation protein sequencing using mass spectrometry and advanced bioinformatics
• Services: Diagnostics, therapies, reagents, and treatments development
• Website: rapidnovor.com

About Rapid Novor

Rapid Novor helps researchers decode immunity so they can rapidly and effortlessly develop diagnostics, therapies, reagents, and treatments. Through antibody discovery and antibody sequencing services Rapid Novor have empowered thousands of researchers.

The innovative next generation protein sequencing technology they have developed has the potential to unlock countless discoveries for human health. Their technology relies on mass spectrometry and advanced bioinformatics that delivers the correct sequence every time – this means you can confidently sequence and recombinantly express mAbs starting only with a small sample of protein from any species.

Unlock the full potential of your research with Rapid Novor and evitria

By partnering with Rapid Novor, we bring you unparalleled expertise in next-generation protein sequencing, enabling precise and confident recombinant antibody development from even the smallest protein samples. Combined with evitria’s transient antibody expression in CHO cells, our collaborative workflow ensures you receive consistent, high-quality results tailored to your specific needs.

Reach out to us to learn how we can support your research and accelerate your projects with our integrated solutions.